Michael Adasczik
Comptroller/Controller/Auditor en B&G FOODS, INC. .
Fortuna: 225 311 $ al 31/03/2024
Perfil
Michael D.
Adasczik is currently the Chief Accounting Officer & Vice President-Finance at B&G Foods, Inc. Prior to this, he worked as the Principal Accounting Officer at Sio Gene Therapies, Inc. from 2015 to 2018.
Adasczik holds an undergraduate degree and an MBA from Rider University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
B&G FOODS, INC.
0.03% | 25/03/2024 | 19 695 ( 0.03% ) | 225 311 $ | 31/03/2024 |
Cargos activos de Michael Adasczik
| Empresas | Cargo | Inicio |
|---|---|---|
| B&G FOODS, INC. | Comptroller/Controller/Auditor | 12/11/2018 |
Antiguos cargos conocidos de Michael Adasczik.
| Empresas | Cargo | Fin |
|---|---|---|
| SIO GENE THERAPIES INC. | Comptroller/Controller/Auditor | 01/06/2018 |
Formación de Michael Adasczik.
| Rider University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| B&G FOODS, INC. | Consumer Non-Durables |
| Empresas privadas | 1 |
|---|---|
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Adasczik
